Genetic Mutation A Strong Indicator Of Age-Related Hearing Loss Risk
Posted on: Tuesday, 6 October 2009, 15:03 CDT
Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
The study, which collected DNA samples from 55 patients with ARHL, indicated that there exists a significant correlation between the presence of a mutation of the GSTT1 gene, and age-related hearing loss. Conversely, there were no associations linked to the NAT2 gene.
Anti-oxidant enzymes and their deficiencies have also been implicated as contributors to diseases such as cancer and cardiovascular disease.
Title: Anti-oxidant Enzymes and Age-Related Hearing Loss
Author: Anthony Bared, MD and Xue Liu; Simon Angeli, MD
---
On the Net:
Related Articles
- Age-Related Difficulty Recognizing Words Predicted By Brain Differences
- Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
- Cellgate Initiates Phase I Clinical Study in Age-Related Macular Degeneration
- Cochlear Implants Aim for Age-Related Loss
- Preliminary Phase III Data From Head-To-Head Study of Lucentis Shows Lucentis Improved Vision Compared to Visudyne in Patients With Wet Age-Related Macular Degeneration
- Phase III Study Shows Lucentis(TM) Improved Vision in Patients With Wet Age-Related Macular Degeneration
- Obesity, Lutein Metabolism, and Age-Related Macular Degeneration: A Web of Connections
- Molecular and Neural Perspectives on Age-Related Hearing Loss
- O-19: Lipid Peroxidation Damage Contributes to the Pathogenesis of Age-Related Macular Degeneration
 |
 |
User Comments (0)
RSS Feeds